This is a Form 3 filing for Paul Miele, Senior Vice President and Chief Commercial Officer of Accuray Incorporated (ticker: ARAY). The filing reports that as of April 6, 2026, Mr. Miele does not beneficially own any securities of the company. The document includes a power of attorney executed on April 6, 2026, authoriz...

Lawrence Bernard Gozlan, a director at ALTERITY THERAPEUTICS LTD (ATHE), has filed an initial statement of beneficial ownership. The filing, dated April 10, 2026, details holdings through Montoya Pty Ltd <Buttercup A/C>. Gozlan holds 4,545,555 ordinary shares indirectly. Additionally, he holds 1,515,152 listed options ...

This Form 3 filing reports that Julian Michael Babarczy, a director of Alterity Therapeutics Ltd (ATHE), has no securities ownership in the company as of April 10, 2026. The filing indicates that Babarczy serves as a director but does not hold any ownership position in the company's securities. The filing was submitted...

This filing reports a change in beneficial ownership of securities for Peter Ashley Marks, a director at ALTERITY THERAPEUTICS LTD. The changes involve both derivative and non-derivative holdings. Specifically, there are listed options expiring on February 26, 2027, and unlisted options expiring on December 30, 2027. T...

This filing details restricted stock units (RSUs) granted to Jin Cao, Chief Accounting Officer of Ascentage Pharma Group International. Each RSU represents a contingent right to one Ordinary Share, vesting in four equal increments on November 26th of 2026, 2027, 2028, and 2029. The filing also includes a Power of Attor...

This filing details a Power of Attorney granted by Thomas A. Zalewski, Chief Legal Officer of Aquestive Therapeutics, Inc., to Hillary T. Yegen, Ellen S. Knarr, and Christopher M. Rogers. The attorneys-in-fact are authorized to prepare and execute necessary documents for electronic SEC filings, including Forms 3, 4, 5,...

This filing reports initial beneficial ownership of securities by Thierry Bernard, a director at BRUKER CORP. The report, filed on April 7, 2026, pertains to the period ending April 1, 2026. Mr. Bernard resides at 40 Manning Rd, Billerica, MA 01821. As a director, this filing is an initial disclosure of his holdings. T...

This filing is an initial report of beneficial ownership (Form 3) for Jorge Francisco Betzhold, who is a director at BUENAVENTURA MINING CO INC (BVN). The report indicates that Mr. Betzhold has no securities owned as of April 10, 2026. The filing details his non-US address in Pombal, Portugal. This form is typically fi...

This Form 3 filing reports that Julian Michael Babarczy, a director of Alterity Therapeutics Ltd (ATHE), has no securities ownership in the company as of April 10, 2026. The filing indicates that Babarczy serves as a director but does not hold any ownership position in the company's securities. The filing was submitted...

This filing reports initial beneficial ownership of securities by Thierry Bernard, a director at BRUKER CORP. The report, filed on April 7, 2026, pertains to the period ending April 1, 2026. Mr. Bernard resides at 40 Manning Rd, Billerica, MA 01821. As a director, this filing is an initial disclosure of his holdings. T...

This filing is an initial report of beneficial ownership (Form 3) for Jorge Francisco Betzhold, who is a director at BUENAVENTURA MINING CO INC (BVN). The report indicates that Mr. Betzhold has no securities owned as of April 10, 2026. The filing details his non-US address in Pombal, Portugal. This form is typically fi...

This is a Form 3 filing by Shaoyu Yan, who has become a director of BioLineRx Ltd. (NASDAQ: BLRX). The filing represents Yan's initial statement of beneficial ownership of securities in the company, as required when a person becomes a director, officer, or beneficial owner of more than 10% of a class of equity securiti...

This filing reports the initial beneficial ownership of Jianjun Gao, who is a director at Bon Natural Life Ltd. The reporting owner, registered as GAO JIANJUN, resides in Xi'an, China. The document, a Form 3, indicates that the reporting owner has no securities owned as of the period of report, April 2, 2026. The signa...

This filing reports on the ownership of Bon Natural Life Ltd. (BON) by Jing Liu. Jing Liu holds 2,004,427 Class B ordinary shares, which are convertible into 80,177 Class A ordinary shares. The filing also indicates that Jing Liu directly owns 1496 Class A ordinary shares. Additionally, Jing Liu holds a derivative secu...

This filing reports the initial beneficial ownership of securities by WENJUAN CHEN, Chief Marketing Officer of Bon Natural Life Ltd. The filing indicates that Ms. Chen, through Lavender Oil Limited, beneficially owns 80 Class A Ordinary Shares. The nature of ownership is indirect, as detailed in footnote 1. The reporti...

This filing is an Initial Statement of Beneficial Ownership (Form 3) for MA XIN, the Chief Financial Officer of Bon Natural Life Ltd. The report date is April 2, 2026. MA XIN is reporting beneficial ownership of securities in Bon Natural Life Ltd. The filing indicates that there are no securities owned by the reporting...

This filing details the beneficial ownership of securities by XUE YINGCHUN, Chief Operating Officer of Bon Natural Life Ltd. The filing indicates that XUE YINGCHUN, through Lavender Oil Limited, beneficially owns 120 Class A Ordinary Shares. The shares are held indirectly, with the reporting person having a proportiona...

This filing details the ownership of Bon Natural Life Ltd by Hu Yongwei, the CEO and a director. It indicates that Hu Yongwei directly owns 2,004,427 Class B ordinary shares, which are convertible into 80,177 Class A ordinary shares at his discretion. The filing also notes that Hu Yongwei is a 10% owner of the company....

This filing details changes in beneficial ownership for Borqs Technologies, Inc. (BRQSF). Ji (Richard) Li, identified as a director, reported a post-transaction ownership of 386,615 ordinary shares. The ownership is direct. The reporting owner, Li Ji (Richard), resides in Hong Kong. The filing date was April 10, 2026, ...

This is a Form 3 initial statement of beneficial ownership filing for Ng Yah Ling, who serves as a director of CCH Holdings Ltd (ticker: CCHH). The filing was signed on April 10, 2026, with a reporting period ending March 18, 2026. Ng Yah Ling is based in Bukit Mertajam, Pulau Pinang, Malaysia, and holds the position o...

This Form 3 filing reports that Yaohui Wang, a director of CDT Environmental Technology Investment Holdings Ltd (CDTG), has no securities ownership in the company as of March 18, 2026. The filing was signed on April 10, 2026, and indicates that Wang holds the position of director but does not own any shares of the comp...

This filing reports that Marcelo Dodsworth Penna has been appointed as a director at CI&T Inc. The filing, dated April 10, 2026, indicates that Mr. Penna will hold a director position. His reporting address is listed as 800 Boylston Street, Suite 3300, Boston, MA 02199. This is an initial filing of beneficial ownership...

This filing is an initial report (Form 3) for Juan Lizardo Paredes Manrique, a director at CREDICORP LTD (BAP). The report, dated March 31, 2026, indicates that Mr. Manrique directly owns 265 common shares of the company following the transaction. No other ownership details or transactions are specified in this filing....

This filing details restricted stock units (RSUs) granted to Jin Cao, Chief Accounting Officer of Ascentage Pharma Group International. Each RSU represents a contingent right to one Ordinary Share, vesting in four equal increments on November 26th of 2026, 2027, 2028, and 2029. The filing also includes a Power of Attor...

This filing is an exhibit detailing a Power of Attorney granted by Martin Patrick Murphy, a director at Century Therapeutics, Inc. (IPSC). The document, dated December 9, 2025, and effective April 10, 2026, appoints Brent Pfeiffenberger, Douglas Carr, and Gregory Russotti as attorneys-in-fact. They are authorized to ex...